47.27 USD
+3.43 (+7.82%)
47.4634 USD
+0.19 (+0.41%)
Taking everything into account, BRKR scores 4 out of 10 in our fundamental rating. BRKR was compared to 58 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
In the past year BRKR had a positive cash flow from operations.
In the past 5 years BRKR has always been profitable.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRKR's Return On Assets of -0.37% is fine compared to the rest of the industry. BRKR outperforms 65.52% of its industry peers.
BRKR's Return On Equity of -0.97% is fine compared to the rest of the industry. BRKR outperforms 65.52% of its industry peers.
BRKR has a better Return On Invested Capital (4.01%) than 68.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 13.56%.
The last Return On Invested Capital (4.01%) for BRKR is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin has declined in the last couple of years.
BRKR's Operating Margin of 8.99% is fine compared to the rest of the industry. BRKR outperforms 65.52% of its industry peers.
In the last couple of years the Operating Margin of BRKR has declined.
Looking at the Gross Margin, with a value of 48.00%, BRKR is in line with its industry, outperforming 51.72% of the companies in the same industry.
BRKR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
BRKR has an Altman-Z score of 2.40. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score of 2.40. This is in the better half of the industry: BRKR outperforms 62.07% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that BRKR is somewhat dependend on debt financing.
BRKR's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. BRKR is outperformed by 77.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.4 |
ROIC/WACC0.43
WACC9.4%
2.3 Liquidity
A Current Ratio of 1.85 indicates that BRKR should not have too much problems paying its short term obligations.
BRKR has a worse Current ratio (1.85) than 60.34% of its industry peers.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, BRKR is doing worse than 86.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -18.37% in the last year.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
Looking at the last year, BRKR shows a small growth in Revenue. The Revenue has grown by 6.10% in the last year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
Based on estimates for the next years, BRKR will show a small growth in Earnings Per Share. The EPS will grow by 4.89% on average per year.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.64, the valuation of BRKR can be described as rather expensive.
Based on the Price/Earnings ratio, BRKR is valued cheaper than 81.03% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.45. BRKR is around the same levels.
With a Price/Forward Earnings ratio of 20.48, BRKR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 84.48% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, BRKR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.64 | ||
| Fwd PE | 20.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.96 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.64
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
5. Dividend
5.1 Amount
With a yearly dividend of 0.46%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.48, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.66% of the companies listed in the same industry.
With a Dividend Yield of 0.46, BRKR pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
BRKR's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
47.27
+3.43 (+7.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner Change6.88%
Ins Owners26.98%
Ins Owner Change0.24%
Market Cap7.17B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts76.19
Price Target47.46 (0.4%)
Short Float %13.43%
Short Ratio4.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)-0.56%
PT rev (3m)-1.83%
EPS NQ rev (1m)-18.72%
EPS NQ rev (3m)-21.18%
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-19.75%
Revenue NQ rev (1m)-3.01%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-2.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.64 | ||
| Fwd PE | 20.48 | ||
| P/S | 2.09 | ||
| P/FCF | N/A | ||
| P/OCF | 76.05 | ||
| P/B | 2.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.96 |
EPS(TTM)2
EY4.23%
EPS(NY)2.31
Fwd EY4.88%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.31%
SpS22.67
BVpS16.03
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.64
Graham Number26.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.4 |
F-Score5
WACC9.4%
ROIC/WACC0.43
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.69%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status of BRUKER CORP (BRKR) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP (BRKR) stock?
The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -17.24% in the next year.
Is the dividend of BRUKER CORP sustainable?
The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.